Source: The Lancet
Expression of concern: Hydroxychloroquine or chloroquine
with or without a macrolide for treatment of COVID-19:
a multinational registry analysis.
Important scientific questions have been raised about
data reported in the paper by Mandeep Mehra et al—
Hydroxychloroquine or chloroquine with or without a
macrolide for treatment of COVID-19: a multinational
registry analysis (1) – published in The Lancet on May 22, 2020
Although an independent audit of the provenance
and validity of the data has been commissioned by the
authors not affiliated with Surgisphere and is ongoing,
with results expected very shortly, we are issuing an
Expression of Concern to alert readers to the fact that
serious scientific questions have been brought to our
attention. We will update this notice as soon as we have
further information.
The Lancet Editors
The Lancet, London EC2Y 5AS, UK
(1)
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or
chloroquine with or without a macrolide for treatment of COVID-19:
a multinational registry analysis. Lancet 2020; published online May 22.
https://doi.org/10.1016/S0140-6736(20)31180-6
Related: LancetGate: Surgisphere – is the company which provided the data to the study serious?
